Management Stock Option Plans: Where the Shares Come From and Who Pays for Incentives

A management stock option plan is a way of paying executives not with the company's cash but with a stake in it: a manager receives the right, several years later, to buy shares at a price fixed in advance, or to receive the shares themselves once certain conditions are met. From a corporate finance perspective, three things matter here, and none of them is about motivation: where the shares for the plan come from, how the expense is reflected in the financial statements, and at whose expense the dilution takes place. Shareholders always pay for such a plan — the only question is whether they pay in cash from the company's coffers or with their own stake in the equity.

What exactly the manager receives

The umbrella term "option plan" covers a range of different structures. A classic option is the right to buy a share at the exercise price (the strike), fixed at the grant date; the manager gains only on the increase above the strike. Restricted stock units (RSU) are a promise to transfer the share itself once a set date arrives, with no payment required for it; this is more valuable to the recipient and more expensive for the company, because its value does not fall to zero if the share price stagnates. Phantom options and SAR do not touch the equity at all: the company pays out in cash the difference between the price on the exercise date and a base price. A phantom plan does not dilute shareholders' stakes, but it creates a cash liability that is remeasured in line with the share price and hits earnings precisely when the stock is rising.

Where the shares for the plan come from

There are only a few sources, and the choice of source is the key corporate decision.

The first is an additional share issue. It is the cheapest option for the treasury and the most expensive for minority shareholders: the stake of existing shareholders shrinks, and earnings per share are spread over a larger number of shares.

The second is a treasury or quasi-treasury stake built up earlier through a buyback programme. No cash is spent at the moment of transfer, but it was spent earlier, at the time of the buyback — and a share repurchase that ends up funding incentives does not return capital to shareholders; it shifts it to management.

The third is buying shares in the market as the exercise dates arrive. This is an honest cash expense, but the company takes on price risk: the more the stock has risen, the more expensive the plan becomes.

Vesting, strike and exercise conditions

The vesting period stretches over several years, often with a minimum cliff before which nothing vests at all. This is a retention mechanism: leaving the company early wipes out the unexercised portion. Conditions can be time-based (simply staying on until a certain date) or performance-based — linked to share price growth, to total shareholder return, to leverage or to operating metrics. This is exactly where the quality of a plan is determined for an outside investor: a link to the absolute share price rewards management for a general market rally, while a link to performance relative to industry peers rewards it for actual work. Repricing the strike after a fall in the share price deserves particular scrutiny: such a reset relieves management of the very risk that was the whole point of the structure.

How it flows through the financial statements

Share-based payments are recognised as an expense in the income statement over the vesting period; they are measured at the grant date and, for equity-settled plans, are not subsequently remeasured to market. The expense is non-cash: it reduces net profit but does not affect cash flow, which is why management likes to exclude it from adjusted metrics. The exclusion is both convenient and contentious: dilution of shareholders' stakes is a very real cost. For phantom plans the logic is different: the liability is remeasured at every reporting date, and the expense swings in line with the share price.

What an investor should check

Diluted earnings per share, not basic. The number of shares outstanding and how it changes from period to period. The note on share-based payments: the number of instruments granted and outstanding, the conditions, and the range of exercise prices. Decisions by shareholder meetings and boards of directors on additional share issues and on the acquisition of the company's own shares. All of this should be taken from primary sources — issuers' financial reports and the corporate events calendar; share prices and the list of traded securities are in the stocks section.

Russian specifics and an honest caveat

In the Russian market, shares earmarked for incentive plans are often held through a closed-end mutual fund or a subsidiary — hence the "quasi-treasury" stake, which is not formally classed as treasury stock and retains its voting rights. Disclosure varies widely between issuers: some publish full tables by instrument, others a single line in a note. The recipient incurs tax both when the benefit is received and on the subsequent sale of the shares, and on different grounds in each case — specific rates and procedures should be checked against the current version of the Tax Code rather than a secondhand summary.

The platform does not maintain a separate database of option plan parameters — strikes, vesting schedules and the volume of instruments granted. This means they will have to be checked manually against the issuer's disclosures. Corporate finance instruments with similar names but a different substance are covered in the glossary: the bond programme deals with raising debt, while the share buyback programme covers the very source of shares from which the incentive pool is most often filled.